Application number  =>  436/MUMNP/2012 A 

Date of filing of application number  =>  21/02/2012 

Publication date  =>  31/08/2012 

Title  =>  GALECTIN-3 AND CARDIAC RESYNCHRONIZATION THERAPY 

Name of applicant  =>  1)BG MEDICINE, INC. 

Name of inventor  =>  1)MUNTENDAM, PIETER 

International Classification  =>  G01N 33/68 

Priority Doc No  =>  61/236,712 

International Application Number  =>  PCT/US2010/046689 

International Publication Number  =>  WO/2011/031493 

Abstract  =>  The present invention relates to materials and methods for monitoring and predicting a heart failure patients physiological response to cardiac resynchronization therapy. More specifically, the present invention relates to the endogenous protein galectin-3 and its use in monitoring progression of disease in a patient undergoing cardiac resynchronization therapy, and as a predictor of response to cardiac resynchronization therapy. 

